↓ Skip to main content

Tratamento da nefrolitíase: onde está a evidência dos ensaios clínicos?

Overview of attention for article published in Jornal Brasileiro de Nefrologia, January 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#7 of 364)
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

blogs
2 blogs
video
1 YouTube creator

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
60 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Tratamento da nefrolitíase: onde está a evidência dos ensaios clínicos?
Published in
Jornal Brasileiro de Nefrologia, January 2016
DOI 10.5935/0101-2800.20160015
Pubmed ID
Authors

Maria Aparecida Pachaly, Cristina Pellegrino Baena, Mauricio de Carvalho

Abstract

The prevalence of kidney stone disease is increasing worldwide with significant health and economic burden. Newer research is finding that stones are associated with several serious morbidities. Yet, few randomized clinical trials or high quality observational studies have assessed whether clinical interventions decrease the recurrence of kidney stones. Therefore, in this review we analyze the available evidence on medical expulsive therapy for ureteral stones; describe the evidence about non-pharmacological stone therapy including dietary modifications and citrus juice-based therapy; and discuss the efficacy of thiazide diuretics for the treatment of hypercalciuria in recurrent nephrolithiasis.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 60 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 15 25%
Student > Doctoral Student 6 10%
Student > Master 5 8%
Researcher 4 7%
Student > Ph. D. Student 4 7%
Other 9 15%
Unknown 17 28%
Readers by discipline Count As %
Medicine and Dentistry 23 38%
Nursing and Health Professions 7 12%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Social Sciences 2 3%
Unspecified 1 2%
Other 4 7%
Unknown 20 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 March 2020.
All research outputs
#2,443,646
of 25,374,917 outputs
Outputs from Jornal Brasileiro de Nefrologia
#7
of 364 outputs
Outputs of similar age
#40,182
of 399,677 outputs
Outputs of similar age from Jornal Brasileiro de Nefrologia
#1
of 20 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 364 research outputs from this source. They receive a mean Attention Score of 2.5. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 399,677 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.